US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.709
- +0.029+4.19%
Trading Nov 27 13:19 ET
181.29MMarket Cap-4242P/E (TTM)
0.731High0.682Low3.14MVolume0.689Open0.680Pre Close2.21MTurnover1.98%Turnover RatioLossP/E (Static)255.88MShares2.05052wk High2.26P/B112.42MFloat Cap0.43052wk Low--Dividend TTM158.68MShs Float21.570Historical High--Div YieldTTM7.21%Amplitude0.420Historical Low0.703Avg Price1Lot Size
About Adaptimmune Therapeutics Company
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Company Profile
SymbolADAP
Company NameAdaptimmune Therapeutics
Listing DateMay 6, 2015
Issue Price17.00
Founded2008
CEOMr. Adrian Rawcliffe
MarketNASDAQ
Employees449
Securities TypeDR
ADS Ratio1.0 : 6.0
Fiscal Year Ends12-31
Address60 Jubilee Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RX
Phone44-1235-430000
Websitehttp://www.adaptimmune.com
Company Executives
- Name
- Position
- Salary
- Adrian Rawcliffe
- Director and Chief Executive Officer
- 2.77M
- James J. Noble
- Chief Executive Officer and Director
- --
- Cintia Piccina
- Chief Commercial Officer
- --
- Dr. Elliot Norry
- Chief Medical Officer
- 1.18M
- Dr. Joanna Brewer
- Chief Scientific Officer
- --
- Gavin Hilary James Wood
- Chief Financial Officer and Principal Accounting Officer
- 1.17M
- William C. Bertrand, Jr
- Chief Operating Officer
- 1.22M
- Dr. Helen Tayton-Martin, PhD
- Chief Business and Strategy Officer
- 1.18M
- John Lunger
- Chief Patient Supply Officer
- --
- David M. Mott
- Chairman of the Board
- 174.83K
- Lawrence M. Alleva
- Independent Director
- 128.80K
- Dr. Kristen M. Hege, M.D.
- Independent Director
- 72.63K
- John P. Furey
- Independent Director
- 117.25K
- Dr. Andrew R. Allen, M.D.,PhD
- Independent Director
- 83.50K
- Dr. Ali Behbahani, M.B.A.,M.D.
- Independent Director
- 111.54K
- Dr. Priti Hegde, PhD
- Independent Director
- 82.25K
- Dr. Garry E. Menzel, PhD
- Independent Director
- 117.29K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
